Eulexin Capsule
Product Images NDC 80725-600

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Eulexin (NDC 80725-600). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Waylis Therapeutics Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Eulexin 01)

Chemical structure of Flutamide. The diagram shows the molecular structure with a trifluoromethyl group (CF3), a nitro group (NO2) attached to an aromatic ring, connected to an amide group (NH-CO) and other substituents consistent with the Flutamide molecule.*

FDA Label Image

Principal Display Panel (125 mg Capsule Bottle Label)

Label for Eulexin 125 mg capsules, containing the active ingredient Flutamide, USP. The label indicates the product is for oral use, prescription only, and contains 180 capsules. It is manufactured by Waylis Therapeutics LLC in Wixom, MI. Storage instructions specify 20° to 25°C (68° to 77°F) with a light-resistant, child-resistant container as required.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.